EFACog is a single-center prospective cohort feasibility study conducted on a single group of patients to study the feasibility of a personalized support program by a nurse conducted over 9 months, using face-to-face and telephone interviews. The objective of this support program is to prevent the occurrence of post-chemotherapy cognitive impairment. After a pre-inclusion visit, patients with no pre-existing cognitive impairment will be included in the study and will receive a 9-month follow-up after the first course of chemotherapy. All follow-up visits (telephone or face-to-face) will be scheduled in conjunction with those taking place in the care setting.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
50
face to face interview : before the first chemotherapy treatment (M0), then at 3 months (M3), 6 months (M6) and 9 months (M9) after the first chemotherapy treatment. Telephonic interview : every month between two face-to-face interviews, i.e. at 1 month after the first treatment (M1), at 2 months (M2), at 4 months (M4), at 5 months (M5), at 7 months (M7) and at 8 months (M8) after the first chemotherapy treatment.
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, Vandoeuvres Les Nancy, France
To assess program feasibility
Rate of patients who participated in all provider interviews (face-to-face and telephone contacts).
Time frame: 9 months
The cognitive complaint
The cognitive complaint will be assessed by the FACT-Cog questionnaire comprising 37 items.
Time frame: 9 months
The Quality of life of patients
Quality of life will be assessed by the generic QLQ-C30 questionnaire of 30 items.
Time frame: 9 months
Fatigue
Fatigue will be assessed by the QLQ-FA12 questionnaire of 12 items.
Time frame: 9 months
Anxiety and depression
Anxiety/depression will be assessed by the 14-item HADS questionnaire (7 items: anxiety / 7 items: depression).
Time frame: 9 months
Appearance of neurocognitive disorders and/or significant cognitive complaints
The appearance of neurocognitive disorders and/or significant cognitive complaints will be assessed by taking the MoCA (Montreal Cognitive Assessment) and QPC (Semi-structured Cognitive Complaint Questionnaire) tests.
Time frame: 9 months
Satisfaction of patients
Satisfaction will be assessed by a numerical scale (0: not satisfied to 10: very satisfied).
Time frame: 9 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.